Risk factors of hearing loss in neonates older than 6 months with history of hospitalization in intensive care unit

Zarrin Keihani-Doust, Aydin Tabrizi, Elahe Amini, Mojtaba Sedaghat, Amir-Ali Ghahremani, Zahra Farahani, Mamak Shariat, Zeinab Kavyani

Abstract


62

Objectives: Hearing loss is one of the most important disabilities in neonates. Delay in detection of hearing loss leads to impaired development and may prevent the acquisition of speech. The present study was designed to determine the risk factors associated with hearing loss in neonatal patients aged more than 6 months with history of hospitalization in Neonatal Intensive Care Unit (NICU).

Methods: In this case-control study, screening for hearing loss was carried out on 325 neonates aged 6-12 months who referred to pediatric neurology office of  Vali-e-Asr hospital, Tehran, iran. Hearing loss has confirmed using Acoustic Brain Audiometry (ABR) screening test.

Results: The prevalence of hearing loss in neonates was determined about 3.6%. The most significant risk factors for hearing loss in neonates were neonatal icterus associated with phototherapy, respiratory distress syndrome (RDS) and lower Apgar score.

Conclusion: Considering significant prevalence of hearing loss among studied neonates, screening all newborns is still seems valuable and cost effective.


Keywords


Hearing loss, neonates, risk factor, Acoustic Brain Audiometry

Full Text:

PDF

64

PDF

64

References


Uchôa NT, Procianoy RS, Lavinsky L, Sleifer P. Prevalence of hearing loss in very low birth weight neonates. Jornal de pediatria. 2003;79(2):123-8.

Arnold J, Radkowski D, Fanaroff A, Martin R. Hearing loss in the newborn infant. Neonatal-Perinatal Medicine Diseases of the Fetus and Infant Fanaroff Avroy, Martin Richard editors. 2006;6:958-63.

Erenberg A, Lemons J, Sia C, Tunkel DE, Ziring P, Adams M, et al. Newborn and infant hearing loss. Pediatrics. 1999;103(2):527-30.

Hearing JCoI. Year 2007 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2007;120(4):898-921.

Finitzo T, Albright K, O'Neal J. The newborn with hearing loss: detection in the nursery. Pediatrics. 1998;102(6):1452-60.

Norton S, Perkins J. Early Diagnosis and Detection of Infant Hearing Impairment. Cummings CW: Otolaryngology Head and Neck Surgery.4:4387-97.

Oghalai JS, Chen L, Brennan ML, Tonini R, Manolidis S. Neonatal hearing loss in the indigent. The Laryngoscope. 2002;112(2):281-6.

Kountakis SE, Psifidis A, Chang CJ, Stiernberg CM. Risk factors associated with hearing loss in neonates. American journal of otolaryngology. 1997;18(2):90-3.

Fakhim SA, Naderpoor M, Shahidi N, Basharhashemi F, Nejati N, Sakha SH, et al. Study of prevalence and causes of hearing loss in high risk neonates admitted to neonatal ward and neonatal intensive care unit. Int Adv Otol. 2010;6:365-70.

Fujita A, Hyde M, Alberti P. ABR latency in infants: properties and applications of various measures. Acta oto-laryngologica. 1991;111(1):53-60.

Herrmann BS, Thornton AR, Joseph JM. Automated Infant Hearing Screening Using the ABRDevelopment and Validation. American Journal of Audiology. 1995;4(2):6-14.

Mehl AL, Thomson V. Newborn hearing screening: the great omission. Pediatrics. 1998;101(1):e4-e.

Hearing JCoI, Pediatrics AAo, Association AS-L-H. Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2000;106(4):798-817.

Farhadi M, Mahmoudian S, Mohammad K, Daneshi A. The pilot study of a nationwide neonatal hearing screening in Iran: Akbarabadi and Mirzakouchak-Khan hospitals in Tehran (June 2003-October 2004). 2006.

Fakhraee SH, Kazemian M, Hamidieh A-A. Hearing Assessment of the High Risk Neonates Admitted to Mofid Hospital for children During 2001–2002, using Auditory Brainstem Response (ABR). Birth. 2004;18(8):10.

Zamani A, Daneshjou K, Tak AAJ. Estimating the incidence of neonatal hearing loss in high risk neonates. Acta Medica Iranica. 2004;42(3):176-80.

Yoshikawa S, Ikeda K, Kudo T, Kobayashi T. The effects of hypoxia, premature birth, infection, ototoxic drugs, circulatory system and congenital disease on neonatal hearing loss. Auris Nasus Larynx. 2004;31(4):361-8.

Chiong CM, Dv Llanes EG, Tirona-Remulla AN, Calaquian CME, Reyes-Quintos M-RT. Neonatal hearing screening in a neonatal intensive care unit using distortion-product otoacoustic emissions. Acta oto-laryngologica. 2003;123(2):215-8.

Maisoun AM, Zakzouk SM. Hearing screening of neonates at risk. Saudi medical journal. 2003;24(1):55-7.

Amin SB, Saluja S, Saili A, Laroia N, Orlando M, Wang H, et al. Auditory toxicity in late preterm and term neonates with severe jaundice. Developmental Medicine & Child Neurology. 2016.

Wroblewska-Seniuk K, Greczka G, Dabrowski P, Szyfter W, Mazela J. The results of newborn hearing screening by means of transient otoacoustic emissions–has anything changed over 10 years? International Journal of Pediatric Otorhinolaryngology. 2017;96:4-10.

Poonual W, Navacharoen N, Kangsanarak J, Namwongprom S. Risk factors for hearing loss in infants under universal hearing screening program in Northern Thailand. Journal of multidisciplinary healthcare. 2016;9:1.

Finckh-Krämer U, Gross M, Bartsch M, Kewitz G, Versmold H, Hess M. Hearing screening of high risk newborn infants. Hno. 2000;48(3):215-20.

Yoshinaga-Itano C, Johnson CDC, Carpenter K, Brown AS, editors. Outcomes of children with mild bilateral hearing loss and unilateral hearing loss. Seminars in Hearing; 2008: © Thieme Medical Publishers.




DOI: https://doi.org/10.22037/ijcn.v12i4.17082

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Iranian Journal of Child Neurology